Výsledky vyhledávání - "Benoit Cadieux"

Akademický článek

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach

Autor: Dionna Jacobson, Benoit Cadieux, Celestia S. Higano, David H. Henry, Basia A. Bachmann, Marko Rehn, Alison T. Stopeck, Hossam Saad

Publikováno v: Journal of Bone Oncology, Vol 34, Iss , Pp 100423- (2022)

Background: Clinical practice guidelines recommend the use of bone-targeting agents for preventing skeletal-related events (SREs) among patients with bone metastases from solid tumors. The anti-RANKL monoclonal antibody denosumab is approved for the

Externí odkaz: https://doaj.org/article/d9d83d9457b64c0bb7e80b98fa064670

Zobrazit plný text záznamu

Akademický článek

Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval

Autor: Benoit Cadieux, Robert Coleman, Pegah Jafarinasabian, Allan Lipton, Robert Z. Orlowski, Fred Saad, Giorgio V. Scagliotti, Kazuyuki Shimizu, Alison Stopeck

Publikováno v: Journal of Bone Oncology, Vol 33, Iss , Pp 100416- (2022)

Skeletal-related events (SREs) are complications of bone metastases and carry a significant patient and economic burden. Denosumab is a receptor activator of nuclear factor-κB ligand (RANKL) inhibitor approved for SRE prevention in patients with mul

Externí odkaz: https://doaj.org/article/0e7638b19e4e4d76af625c7c7fd00821

Zobrazit plný text záznamu

Abstract P1-20-02: A machine learning approach to identify risk factors associated with skeletal-related events following denosumab cessation among patients with bone metastases from breast cancer

Autor: Alison Stopeck, Celestia Higano, David Henry, Basia Bachmann, Marko Rehn, Dionna Jacobson, Benoit Cadieux, Hossam Saad

Publikováno v: Cancer Research. 82:P1-20

Background: The anti-RANKL monoclonal antibody denosumab has been demonstrated to be superior to the bisphosphonate zoledronate in preventing skeletal-related events (SREs) among patients with incident bone metastases (BMs) from solid tumors (STs), i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2481ba23a1f1a9144a9bd1dedbfc3cb3
https://doi.org/10.1158/1538-7445.sabcs21-p1-20-02

Zobrazit plný text záznamu

Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer

Autor: Arlene Chan, Danielle Jandial, Robert E. Coleman, Benoit Cadieux, Ying Zhou

Publikováno v: Advances in Therapy

Introduction D-CARE, an international, phase 3, randomized, double-blind, placebo-controlled study in women with early-stage breast cancer at high risk of disease recurrence, failed to meet its primary endpoint—improvement in bone metastasis-free s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c59b0aa3165c8b9f4e6b4ad2c490a3b
https://doi.org/10.1007/s12325-021-01812-9

Zobrazit plný text záznamu

Assessment of Bone Health Education in US Multiple Myeloma and Solid Tumor Patients at Risk for Skeletal-Related Events

Autor: Benoit Cadieux, Guy Boike, Kimberly Lowe, David C Fuehrer, Darcy R. Flora, Katherine B Carlson, Jennifer Schenfeld

Publikováno v: Cancer Management and Research

Darcy R Flora,1 Katherine B Carlson,2 David C Fuehrer,1 Benoit Cadieux,3 Guy Boike,4 Jennifer Schenfeld,2 Kimberly A Lowe2 1GRYT Health Inc., Rochester, NY, USA; 2Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA; 3Global Medical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda3780bd5fce4becebdae99d1ef4e2f
http://europepmc.org/articles/PMC8079256

Zobrazit plný text záznamu

Abstract PS9-69: Findings from the BonE heAlth eduCatiOn needs assessment (BEACON) study: A survey of bone metastatic breast cancer patients at risk for skeletal-related events

Autor: Darcy R. Flora, Katherine B Carlson, Benoit Cadieux, David C Fuehrer, Guy Boike, Kimberly Lowe, Basia A. Bachmann

Publikováno v: Cancer Research. 81:PS9-69

PURPOSE Nearly 40% of patients with bone metastases from breast cancer experience a skeletal-related event (SRE) such as fracture, spinal cord compression, bone surgery, or radiation to bone, within 1 year of diagnosis (1). Bone-targeting agents (BTA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cb92f6e9d73af3891cc1f0843c20cdd9
https://doi.org/10.1158/1538-7445.sabcs20-ps9-69

Zobrazit plný text záznamu

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach

Autor: Dionna Jacobson, Benoit Cadieux, Celestia S. Higano, David H. Henry, Basia A. Bachmann, Marko Rehn, Alison T. Stopeck, Hossam Saad

Publikováno v: Journal of bone oncology. 34

Clinical practice guidelines recommend the use of bone-targeting agents for preventing skeletal-related events (SREs) among patients with bone metastases from solid tumors. The anti-RANKL monoclonal antibody denosumab is approved for the prevention o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487364857cdf6c3e3de5c76cc7e87dff
https://pubmed.ncbi.nlm.nih.gov/35378840

Zobrazit plný text záznamu

Risk factors associated with skeletal-related events following denosumab cessation among patients with bone metastases from solid tumors: A real-world machine learning approach

Autor: Marko Rehn, Benoit Cadieux, Alison Stopeck, Celestia S. Higano, Basia A. Bachmann, Dionna Jacobson, David H. Henry

Publikováno v: Journal of Clinical Oncology. 39:1567-1567

1567 Background: The anti-RANKL monoclonal antibody denosumab has been shown to be superior to the bisphosphonate zoledronate for the prevention of skeletal-related events (SREs) in patients with incident bone metastases (BM) from solid tumors (ST).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a1cb7a1600fae63bdcc8d828fb54636e
https://doi.org/10.1200/jco.2021.39.15_suppl.1567

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání